Compare ELMD & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELMD | OSUR |
|---|---|---|
| Founded | 1992 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.9M | 295.7M |
| IPO Year | 2010 | 2000 |
| Metric | ELMD | OSUR |
|---|---|---|
| Price | $41.58 | $4.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $36.00 | $3.00 |
| AVG Volume (30 Days) | 112.7K | ★ 344.3K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | $54,716,000.00 | ★ $167,064,000.00 |
| Revenue This Year | $15.59 | $4.48 |
| Revenue Next Year | $11.51 | $7.76 |
| P/E Ratio | $44.76 | ★ N/A |
| Revenue Growth | ★ 13.83 | N/A |
| 52 Week Low | $18.14 | $2.08 |
| 52 Week High | $47.40 | $4.58 |
| Indicator | ELMD | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 55.13 |
| Support Level | $23.46 | $3.80 |
| Resistance Level | $47.40 | $4.33 |
| Average True Range (ATR) | 1.81 | 0.19 |
| MACD | -0.25 | 0.00 |
| Stochastic Oscillator | 57.78 | 72.58 |
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.